In August of this year, bookapharmacist.com reported on the antimicrobial iphone app developed by the team at Southampton University Hospital NHS Trust (now: University Hospital Southampton NHS Foundation Trust). At the end of that piece, Kazeem promised to try and get an interview with Dr Kieran Hand, the pharmacist involved in the App development. Well we did! Enjoy the interview:

Interview with Dr Kieran Hand (Consultant Pharmacist – Anti-infectives ; University Hospital Southampton NHS Foundation Trust): Conducted October 2011


Q1:

Dr Hand, you are well known to us here at bookapharmacist.com (1) but can you please introduce yourself and describe your current role at University Hospital Southampton NHS Foundation Trust to those listening for the first time.

A:

 

http://www.iforg.net/podcast/kieran/1.mp3

Q2:

What is the rationale behind this new antimicrobial iphone App which we reviewed in August (2)

A:

 

http://www.iforg.net/podcast/kieran/2.mp3

Q3:

With Mr Lansley calling for healthcare apps ideas (3, 4), would you not say the Trust is showing great clinical leadership in being the first to market? Furthermore, will this not contribute to the clinical transparency debate which is the hallmark of the new Health and Social care bill (5)?

A:

 

http://www.iforg.net/podcast/kieran/3.mp3

Q4:

How easy was it to deliver this app as part of a multidisciplinary team and what tips can you give about this way of working?

A:

 

http://www.iforg.net/podcast/kieran/4.mp3

Q5:

How is the antimicrobial team making sure that prescribing are carried out in accordance with the guideline?

A:

 

http://www.iforg.net/podcast/kieran/5.mp3

Q6:

On a separate issue, I understand you are a keen athlete always finding time to raise money for charity (6). Why the Medical Missionaries of Mary?

A:

 

http://www.iforg.net/podcast/kieran/6.mp3

Thanks very much for your time.

NB: Dr Kieran Hand was featured on the BBC PM program (05/11/2011) raising concerns to government about speeding up the process for approving new antibiotics.